Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Lars Fruergaard Jørgensen - Wikipedia

   en.wikipedia.org/wiki/Lars_Fruergaard_Jørgensen

   CEO at Novo Nordisk. Employer. Novo Nordisk (since 1994) Lars Fruergaard Jørgensen (born 29 November 1966) [1] is a Danish businessman, the Chief Executive of Novo Nordisk since January 2017 and Chairman of the European Federation of Pharmaceutical Industries and Associations . He was named as the Financial Times Person of the Year in December ...

3. Novo Nordisk - Wikipedia

   en.wikipedia.org/wiki/Novo_Nordisk

   Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd [3] with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.

4. Lars Rebien Sørensen - Wikipedia

   en.wikipedia.org/wiki/Lars_Rebien_Sørensen

   October 10, 1954 (age 69) Education. The Royal Veterinary and Agricultural University, University of Copenhagen. Occupation (s) Former CEO at Novo Nordisk, chair of Novo Nordisk Foundation (2020. Employer. Novo Nordisk (until 2016) Lars Rebien Sørensen (born 10 October 1954) [1] is a Danish businessman and former CEO of the pharmaceutical ...

5. Novo Nordisk plans record expansion in NC, promising 1,000 ...

   www.aol.com/novo-nordisk-plans-record-expansion...

   June 24, 2024 at 3:06 PM. Novo Nordisk announced the largest private life science investment in state history Monday, committing $4.1 billion to expand its Johnston County facility, a project the ...

6. Novo Nordisk's unique structure gives it an extra edge — and ...

   www.aol.com/finance/novo-nordisks-unique...

   Since each Class A share is entitled to 100 votes while each Class B share only gets 10 votes, the foundation controls roughly 77% of the voting power, despite holding around 28% of shares. The ...

7. Novo Nordisk CEO Lars Fruergaard Jorgensen at Reuters ...

   www.aol.com/news/novo-nordisk-ceo-lars...

   LONDON (Reuters) - Novo Nordisk CEO Lars Fruergaard Jorgensen spoke at a Reuters Newsmaker event on Friday. Below are some quotes from his interview which focused on the company's hugely popular ...

8. Lotte Bjerre Knudsen - Wikipedia

   en.wikipedia.org/wiki/Lotte_Bjerre_Knudsen

   Lotte Bjerre Knudsen from Novo Nordisk is a new honorary professor at Health, Aarhus University. She is the person behind the discovery of liraglutide, a new class of drugs for Novo Nordisk that are used in the treatment of type 2 diabetes and obesity. External links. The German Wikipedia page for Lotte Bjerre Knudsen.

9. Wegovy-maker Novo Nordisk to spend $4.1 billion to ... - AOL

   www.aol.com/news/wegovy-maker-novo-nordisk-spend...

   Obesity drug-maker Novo Nordisk will spend $4.1 billion to build a U.S. facility to fill injection pens for its hugely popular weight-loss treatment Wegovy and diabetes drug Ozempic, it said on ...